Legal Mushroom Products From Amanita Muscaria Shipped To 37 US States

Canadian-based producer of mushroom-derived health supplements Psyched Wellness Ltd. PSYCF has successfully completed the production and delivery of customers’ pre-orders of its Amanita muscaria extraction product, Calm, now shipped across the U.S. to as many as 37 states.

Psyched aims to create premium mushroom-derived products to potentially lead North America’s emerging functional food category. As such, the company is currently developing a line of Amanita muscaria-derived water-based extracts, teas and capsules towards promoting stress relief and relaxation and assisting with restful sleeping. 

Psyched CCO Matthew Singh sees Calm availability and shipment within the US marketplace as “a huge step forward,” as many Americans struggle with proper sleep, stress and anxiety

“We are excited for all to try Calm and experience the incredible benefits of a product that is wild-foraged, backed by science, and produced in GMP facilities. There is always pressure to rush a product to market; but this scenario required adequate development, calibration and scale before we progressed to mass distribution,” Singh said. 

The company had targeted October as the month for delivery of Calm so as to allow enough time to incorporate feedback and product evolutions from its initial pilot test. And it came. 

Besides achieving this intended time milestone and reopening its online store with a fresh look, Psyched has set its next production target at a late November delivery window and aims to further increase the cadence of its production, product quantities and provide immediate fulfillment turnarounds in the near future.

Photo by Leone Venter on Unsplash

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsPenny StocksPsychedelicsRetail SalesMarketsAmanita MuscariaFunctional Mushroomspsyched
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!
CCC-Oct-24-Banner-1

Click on the image for more info.

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry?

Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. 

Get your tickets now before prices surge by following this link.